Resources
Explore our library of capabilities
Targeted Protein Degradation
We are glad to show you the overview of Axcelead’s platform for molecular glue degrader…
We would like to introduce one of our strengths, high-throughput synthesis technology for bifunctional degrader….
Axcelead’s design-make-test-analysis cycle for bifunctional degrader allows rapid discovery promising compounds. The capability to design…
Axcelead is capable of offering one-stop solution for molecular glue degraders and bifunctional degrader drug…
1 Minute Guide for HTS Platform
At Axcelead, we’re dedicated to developing selective kinase inhibitors using our kinase panel assay. With…
Properly assessing kinase selectivity is crucial in developing protein kinase inhibitor drugs. However, using comprehensive…
At Axcelead, we recognize the importance of HTS follow-up activities in successful drug discovery. Our…
Phenotypic drug discovery is a valuable approach to finding drugs with functional effects in disease…
Global Webinar
Webinar Overview :
Translating animal data to human outcomes remains a major challenge in…
Webinar Overview :
In April, the FDA announced that New Approach Methodologies (NAMs) will be encouraged…
Webinar Overview :
In recent years, targeted drug discovery has become increasingly challenging, making it essential…
Webinar Overview :
The discovery of lead compounds for classical druggable targets has become increasingly efficient;…
Hot Topics
We’re excited to introduce our new integrated drug discovery service, A-Booster. What is A-Booster? A-Booster…
CEO, Yoshi asked Dr. Fumihiro Jinno, who is head of pharmacokinetics testing for IND, about…
Screening Capabilities
Phenotypic screening is a powerful approach to find novel hit / lead compounds and novel…
Mass spectrometry (MS) has been increasingly used for high throughput screening (HTS) because of its…
High-throughput screening (HTS) is the key methodology to identify hit and lead compouds for drug…